10.1186/s12986-020-00535-y 86
To this end, a large population-based cohort study demonstrated that patients with T2DM and liver cirrhosis who were on GLP-1 RAs therapy had a markedly lower risk of mortality, cardiovascular events, decompensated cirrhosis, hepatic encephalopathy, and liver cirrhosis compared to non-GLP-1 RAs users [82]
improvements in joint pain, energy, and inflammation can take a few months. Can GLP-1 medications be used with other diabetes, arthritis, or autoimmune medications
Tangri N, Ferguson T, Leon SJ, Anker SD, Filippatos G, Pitt B, et al
This substantial reduction in food noise with GLP1 RA drugs, when combined with behavioral treatment, is in line with previous anecdotal findings and may serve as an early indicator of treatment response. The team says this finding is important because food noise can make healthy behaviors much harder to maintain over time